# US 2024/0197907 A1 · Dual-Cleavage Ester Linkers for Antibody-Drug Conjugates

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197907 A1
- Document ID: US20240197907A1
- Status: Published application
- Kind: A1
- Application number: 18/268,919
- Filed: 2022-01-13
- Published: 2024-06-20
- Earliest claimed: 2021-01-15
- Applicants: R.P. Scherer Technologies, LLC
- Inventors: Stepan Chuprakov; Ayodele O. Ogunkoya; Penelope M. Drake
- Web page: https://patentgrep.com/patent/US20240197907A1

## CPC

- A61K 47/6807: {the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense}
- A61K 47/68031: {the drug being an auristatin}
- A61K 47/68037: {the drug being a camptothecin [CPT] or derivatives}
- A61K 47/6889: {Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment}
- C07K 5/0205: {containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present disclosure provides antibody-drug conjugate structures, where the antibody-drug conjugate includes a cleavable linker containing an ester group that links the antibody to the drug. The disclosure also encompasses compounds and methods for production of such conjugates. In addition, the disclosure also encompasses pharmaceutical compositions and methods of using the conjugates.

## Claims

### Claim 1

A conjugate of formula (I):
wherein:
W1 is a drug;
W2 is a polypeptide;
A is an amino acid residue, where k is 0 or an integer from 1 to 5;
L is a linker;
G is a conjugation moiety;
X1 is selected from:
and —(CHR1)j(CHR2)—;
R1 is selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, substituted heterocyclyl and R3, wherein R1 optionally substituted with R3;
j is 0 or an integer from 1 to 5;
R2 is R3; or R2 is selected from alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl, wherein R2 is substituted with R3;
X2 is —NH— or —C(O)—;
each R3 is independently a glycoside or glycoside derivative.

### Claim 2 (depends on 1)

The conjugate of claim 1, wherein X1 is

### Claim 3 (depends on 1)

The conjugate of claim 1, wherein X1 is —(CHR1)j(CHR2)—.

### Claim 4 (depends on 3)

The conjugate of claim 3, wherein j is 0.

### Claim 5 (depends on 4)

The conjugate of claim 4, wherein R2 is alkyl.

### Claim 6 (depends on 4)

The conjugate of claim 4, wherein R2 is aryl.

### Claim 7 (depends on 3)

The conjugate of claim 3, wherein j is 1.

### Claim 8 (depends on 7)

The conjugate of claim 7, wherein R1 is hydrogen.

### Claim 9 (depends on 7)

The conjugate of claim 7, wherein R1 is substituted with R3.

### Claim 10 (depends on 1)

The conjugate of claim 1, wherein each R3 is independently selected from:

### Claim 11 (depends on 1)

The conjugate of claim 1, wherein the conjugate is of formula (II):
wherein R4 is an amino acid side chain.

### Claim 12 (depends on 11)

The conjugate of claim 11, wherein the conjugate is selected from:

### Claim 13 (depends on 1)

The conjugate of claim 1, wherein the conjugate is of formula (III):
wherein R4 is an amino acid side chain.

### Claim 14 (depends on 13)

The conjugate of claim 13, wherein the conjugate is selected from:

### Claim 15 (depends on 1)

The conjugate of claim 1, wherein k is 2.

### Claim 16 (depends on 1)

The conjugate of claim 1, wherein L comprises:
-(T1-V1)a-(T2-V2)b-(T3-V3)c-(T4-V4)d-(T5-V5)e-(T6-V6)f-,
wherein
a, b, c, d, e and f are each independently 0 or 1;
T1, T2, T3, T4, T5 and T6 are each independently selected from a covalent bond, (C1-C12)alkyl, substituted (C1-C12)alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl, (EDA)w, (PEG)n, (AA)p, —(CR13OH)m—, 4-amino-piperidine (4AP), meta-amino-benzyloxy (MABO), meta-amino-benzyloxycarbonyl (MABC), para-amino-benzyloxy (PABO), para-amino-benzyloxycarbonyl (PABC), para-aminobenzyl (PAB), para-amino-benzylamino (PABA), an acetal, a hydrazine, a disulfide, and an ester, wherein EDA is an ethylene diamine moiety, PEG is a polyethylene glycol, and AA is an amino acid residue or an amino acid analog, wherein each w is an integer from 1 to 20, each n is an integer from 1 to 30, each p is an integer from 1 to 20, and each m is an integer from 1 to 12;
V1, V2, V3, V4, V5 and V6 are each independently selected from the group consisting of a covalent bond, —CO—, —NR15—, —NR15(CH2)q—, —NR15(C6H4)—, —CONR15—, —NR15CO—, —C(O)O—, —OC(O)—, —O—, —S—, —S(O)—, —SO2—, —SO2NR15—, —NR15SO2— and —P(O)OH—, wherein each q is an integer from 1 to 6;
each R13 is independently selected from hydrogen, an alkyl, a substituted alkyl, an aryl, and a substituted aryl; and
each R15 is independently selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, carboxyl, carboxyl ester, acyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl.

### Claim 17 (depends on 16)

The conjugate of claim 16,
wherein:
T1 is (C1-C12)alkyl and V1 is —CO—;
T2 is an amino acid analog and V2 is —NH—;
T3 is (PEG)n and V3 is —CO—; and
d to f are each 0; or
wherein:
T1 is (C1-C12)alkyl and V1 is —CO—;
T2 is an amino acid analog and V2 is —NH—;
T3 is (PEG)n and V3 is —CONH—;
T4 is (PEG)n and V4 is —CO—;
e and f are each 0.

### Claim 18 (depends on 1)

The conjugate of claim 1, wherein G is:
wherein:
Z is CR10 or N,
R7 is selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl;
R8 and R9 are each independently selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy, amino, substituted amino, carboxyl, carboxyl ester, acyl, acyloxy, acyl amino, amino acyl, alkylamide, substituted alkylamide, sulfonyl, thioalkoxy, substituted thioalkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl, or R8 and R9 are optionally cyclically linked to form a 5 or 6-membered heterocyclyl;
each R10 is independently selected from hydrogen, halogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy, amino, substituted amino, carboxyl, carboxyl ester, acyl, acyloxy, acyl amino, amino acyl, alkylamide, substituted alkylamide, sulfonyl, thioalkoxy, substituted thioalkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl.

### Claim 19 (depends on 1)

The conjugate of claim 1, wherein G is selected from an acetal, a hydrazone, an oxime, a sulfide, a disulfide, a triazole, an ester, and an amide.

### Claim 20

A compound of formula (IV):
wherein:
W1 is a drug;
A is an amino acid residue, where k is 0 or an integer from 1 to 5;
L is a linker;
G is a conjugation moiety;
X1 is selected from:
and —(CHR1)j(CHR2)—;
R1 is selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, substituted heterocyclyl and R3, wherein R1 is optionally substituted with R3;
j is 0 or an integer from 1 to 5;
R2 is R3; or R2 is selected from alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl, wherein R2 is substituted with R3;
X2 is —NH— or —C(O)—;
each R3 is independently a glycoside or glycoside derivative.

### Claim at position 21

-38. (canceled)

### Claim 39 (depends on 1)

A pharmaceutical composition comprising:
a conjugate of claim 1; and
a pharmaceutically-acceptable excipient.

### Claim 40 (depends on 1)

A method comprising:
administering to a subject a conjugate of claim 1.
